Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Cash (2016 - 2025)

Historic Change in Cash for Sunshine Biopharma (SBFM) over the last 14 years, with Q3 2025 value amounting to -$770560.0.

  • Sunshine Biopharma's Change in Cash fell 95020.99% to -$770560.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 million, marking a year-over-year increase of 6457.11%. This contributed to the annual value of -$5.6 million for FY2024, which is 737.89% up from last year.
  • Sunshine Biopharma's Change in Cash amounted to -$770560.0 in Q3 2025, which was down 95020.99% from $1.8 million recorded in Q2 2025.
  • Sunshine Biopharma's Change in Cash's 5-year high stood at $28.5 million during Q2 2022, with a 5-year trough of -$19.0 million in Q4 2022.
  • Over the past 5 years, Sunshine Biopharma's median Change in Cash value was -$335777.0 (recorded in 2021), while the average stood at $454076.6.
  • Its Change in Cash has fluctuated over the past 5 years, first surged by 4195955.08% in 2022, then crashed by 2527024.69% in 2024.
  • Quarter analysis of 5 years shows Sunshine Biopharma's Change in Cash stood at -$335777.0 in 2021, then plummeted by 5547.28% to -$19.0 million in 2022, then skyrocketed by 84.23% to -$3.0 million in 2023, then skyrocketed by 36.95% to -$1.9 million in 2024, then soared by 59.12% to -$770560.0 in 2025.
  • Its last three reported values are -$770560.0 in Q3 2025, $1.8 million for Q2 2025, and -$1.6 million during Q1 2025.